Find and Join

News Logo

• When “available” doesn’t mean “available”

  Mounjaro is available, crows Eli Lilly. Ditto for Zepbound! Novo Nordisk reports the same for Ozempic and Wegovy. Except for one small thing: “Available” is very, very different than “out of shortage.” read more →

• CCH: Are you sure you’re telling the right story?

  It’s easy for the media to get the message wrong, especially when there are players out there deliberately spreading misinformation about pharmacy compounding. You can help them get it right. read more →

• 15 hours that will grow your expertise (and build your patients’ trust)

  You and your team need to operate at the highest ethical and legal standards, and we don’t need to tell you why. Problem: Those standards are complex and constantly changing. If you’re new to compounding, they can be daunting. read more →

• Board nominations are open: APC & Pharmacy Compounding Foundation

  We’re seeking passionate, informed, influential compounding leaders to help guide our alliance as members of the APC Board of Directors and of the Pharmacy Compounding Foundation.  read more →

• Have you seen the new Compounding.com?

  The first iteration of Compounding.com 2.0 is up and live, but there’s much more to come. Check it out and watch it expand! read more →

• Coming soon: EduCon session #2

  The second session of APC’s EduCon, “Practice Pearls for Line Pharmacists and Technicians: USP 795, 797, and 800” (featuring Michael Shafor of the LP3 Network) is coming up soon — on August 19, in fact.  read more →

More News

PCCA Ad

Blank

Medisca Ad

Blank

Fagron Ad

Blank

Wedgewood Ad

Blank

TopiClick Ad

Then: Compounding.com was the focus of the Campaign to Save Compounded Hormones — a place for patients to share their stories and legislators and media to read them.

Now: We’re transitioning Compounding.com to an all-things compounding patient-focused site. We aim to make it a clearinghouse for information — accurate and timely information — for everything from the basics of pharmacy compounding to therapies that are (or soon may be) under fire, like GLP-1 agonists and ketamine. 

The first iteration of Compounding.com 2.0 is up and live, but there’s much more to come. Check it out and watch it expand!